CAR-T cell therapy for multiple myeloma: An update on the current state and future potential
{{output}}
The field of multiple myeloma (MM) has seen significant therapeutic advances over the last decade including the recent advent of Chimeric Antigen Receptor T cell (CAR-T) therapy. Currently there are two FDA approved CAR-T products for MM, both targeting B cell... ...
